2.5500
-0.1700
(-6.25%)
At close: January 10 at 3:59:51 PM EST
2.5500
0.00
(0.00%)
After hours: January 10 at 6:55:28 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.45 | -0.39 | -1.74 | -2.05 |
| Low Estimate | -0.45 | -0.39 | -1.74 | -2.05 |
| High Estimate | -0.45 | -0.39 | -1.74 | -2.05 |
| Year Ago EPS | -- | -0.98 | -4.29 | -1.74 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | 225k | -- |
| Sales Growth (year/est) | 0.00% | -- | -100.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -- | -- | -0.47 | -0.46 |
| EPS Actual | -4.42 | -0.98 | -0.74 | -0.46 |
| Difference | -- | -- | -0.27 | 0 |
| Surprise % | -- | -- | -56.98% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.45 | -0.39 | -1.74 | -2.05 |
| 7 Days Ago | -0.45 | -0.39 | -1.74 | -2.05 |
| 30 Days Ago | -0.45 | -0.39 | -1.74 | -1.64 |
| 60 Days Ago | -0.45 | -0.39 | -1.74 | -1.64 |
| 90 Days Ago | -0.45 | -0.39 | -1.74 | -1.64 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IBIO | -- | 60.16% | 59.46% | -17.82% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Initiated | LUCID CAPITAL MARKETS: Buy | 12/17/2024 |
| Initiated | Brookline Capital: Buy | 7/22/2024 |
| Maintains | Chardan Capital: Buy to Buy | 6/3/2024 |
| Initiated | Chardan Capital: Buy | 5/28/2024 |
Related Tickers
JAGX Jaguar Health, Inc.
1.0000
-8.26%
VXRT Vaxart, Inc.
0.7898
-2.42%
SRNE Sorrento Therapeutics, Inc.
0.0005
0.00%
INO Inovio Pharmaceuticals, Inc.
1.9800
-5.26%
TNXP Tonix Pharmaceuticals Holding Corp.
0.2787
+8.87%
OCGN Ocugen, Inc.
0.7866
-5.33%
ENSC Ensysce Biosciences, Inc.
7.49
-5.31%
ADTX Aditxt, Inc.
0.1699
+1.01%
TVGN Tevogen Bio Holdings Inc.
1.4500
+12.40%
MBIO Mustang Bio, Inc.
0.2566
+15.38%